Next Article in Journal
Screening for Distress in Patients with Cancer: Methodologic Considerations
Previous Article in Journal
Evidence-Based Guidelines for the Use of Tyrosine Kinase Inhibitors in Adults with Philadelphia Chromosome–Positive or Bcr-Abl–Positive Acute Lymphoblastic Leukemia: A Canadian Consensus
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 21
Issue 2
10.3747/co.21.1727
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Predictors of Recurrence after Radiotherapy for Non-Melanoma Skin Cancer

by
L. Khan
,
D. Breen
,
L. Zhang
,
J. Balogh
,
G. Czarnota
,
J. Lee
,
M.N. Tsao
and
E.A. Barnes
*
University of Toronto, Toronto, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2014, 21(2), 326-329; https://doi.org/10.3747/co.21.1727
Submission received: 2 January 2014 / Revised: 4 February 2014 / Accepted: 6 March 2014 / Published: 1 April 2014

Abstract

Predictive factors of recurrence were examined in 448 non-melanoma skin cancers (72% basal cell carcinoma, 28% squamous cell carcinoma) treated with radiotherapy. The overall recurrence rate was 15.8% at a median follow-up of 18.4 months. In multivariate analysis, significant factors for recurrence were age (p = 0.0197), tumour size 2 cm or greater (p = 0.0095), immunosuppression (p = 0.0082), and treatment modality (p = 0.0009).
Keywords: skin cancer; recurrence; radiotherapy skin cancer; recurrence; radiotherapy

Share and Cite

MDPI and ACS Style

Khan, L.; Breen, D.; Zhang, L.; Balogh, J.; Czarnota, G.; Lee, J.; Tsao, M.N.; Barnes, E.A. Predictors of Recurrence after Radiotherapy for Non-Melanoma Skin Cancer. Curr. Oncol. 2014, 21, 326-329. https://doi.org/10.3747/co.21.1727

AMA Style

Khan L, Breen D, Zhang L, Balogh J, Czarnota G, Lee J, Tsao MN, Barnes EA. Predictors of Recurrence after Radiotherapy for Non-Melanoma Skin Cancer. Current Oncology. 2014; 21(2):326-329. https://doi.org/10.3747/co.21.1727

Chicago/Turabian Style

Khan, L., D. Breen, L. Zhang, J. Balogh, G. Czarnota, J. Lee, M.N. Tsao, and E.A. Barnes. 2014. "Predictors of Recurrence after Radiotherapy for Non-Melanoma Skin Cancer" Current Oncology 21, no. 2: 326-329. https://doi.org/10.3747/co.21.1727

APA Style

Khan, L., Breen, D., Zhang, L., Balogh, J., Czarnota, G., Lee, J., Tsao, M. N., & Barnes, E. A. (2014). Predictors of Recurrence after Radiotherapy for Non-Melanoma Skin Cancer. Current Oncology, 21(2), 326-329. https://doi.org/10.3747/co.21.1727

Article Metrics

Back to TopTop